Short answer
NEOGENOMICS INC (NEO) filed an 8-K current report with the SEC on July 22, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events). July 20, 2026 press release tied to a settlement agreement.
NEOGENOMICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- July 20, 2026 press release tied to a settlement agreement
- Settlement represents potentially material legal, financial, or operational implications for shareholders
- Investors should review the accompanying exhibit for settlement terms and quantified impact
Item 8.01 · Other Events
- DOJ civil settlement finalized July 20, 2026, resolving investigation into consulting services for healthcare providers
- $9.813 million payment obligation, below the $11.2 million reserve recorded March 31, 2026
- Settlement addresses federal healthcare fraud, waste and abuse concerns involving consulting agreements
- No admission of liability by NeoGenomics or concession by the U.S. government on claim validity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NEOGENOMICS INC 8-K filings
Get the next NEO 8-K as it lands
Follow NEO for push alerts, or ask the research agent what this filing means.